Hints and tips:
Related Special Reports
...Hipgnosis Songs Fund and Hipgnosis Song Management declined to comment on Mercuriadis’s proposal....
...Hipgnosis was founded by music executive Merck Mercuriadis in 2018 to turn music rights into a mainstream asset class, using the royalties from streaming, radio play and performances to provide income for...
...Earnings: Amazon, Merck, Bristol Myers Squibb, UPS, Northrop Grumman, Honeywell, Altria, Hershey, Mastercard and Royal Caribbean report earnings before the opening bell....
...Pfizer, Merck and Sanofi have led the M&A revival this year by announcing multibillion-dollar acquisitions, even as dealmaking across other market sectors has fallen sharply due to rising interest rates...
...And it takes time to change the culture,” said Funtleyder, whose fund owns shares in Merck and Lilly but not Pfizer....
...Merck had been in talks to acquire Seagen last summer, offering about $200 a share, according to people familiar with the matter....
...In 2020, Merck took a $1bn stake in SeaGen, as part of a deal to co-develop an antibody-based drug for breast cancer and other solid tumours and to license another drug for cancers that overexpress the HER2...
...The contracts will give the UK access to 1.75m additional courses of Merck Sharp and Dohme’s antiviral Lagevrio and an extra 2.5m courses of Pfizer’s Paxlovid pill....
...But some investors remain cautious about this 2027 sales forecast due to a sharp fall in demand for Covid jabs, globally....
...sharp fall in deposits this quarter....
...We expect the same technology, deployed by the likes of Moderna and Merck, to produce vaccines against some forms of cancer. Science is finally starting to cut the Big C down to size....
...The conditions appear ripe for an M&A boom: big drugmakers are sitting on almost $300bn of cash and many, including Merck and Bristol-Myers-Squibb, need to refill their pipelines because of major patent...
...McDonald’s, Mastercard, Northrop Grumman, Merck, Caterpillar, Altria, Southwest Airlines, Hertz, Oshkosh, Honeywell, Lazard Asset Management and Janus Henderson report before the market opens....
...One investment by Working Capital that is achieving scale is Altana AI, a New York-based start-up whose clients include US Customs and Border Protection, BMW, Merck and Maersk....
...Merck Covid pill: A group that advises the US Food and Drug Administration is scheduled to meet later today to determine whether to grant emergency use authorisation to Merck’s experimental Covid-19 pill...
...Other chip tool and materials makers such as Applied Materials, Merck and Entegris will also add hundreds of jobs in Taiwan....
...Merck....
...In sharp contrast to the speedy and successful development of Covid-19 vaccines, drugs to tackle the virus directly are only just heading into the last stage of trials, with Merck and Pfizer launching the...
...In sharp contrast to the speedy and successful development of Covid vaccines, drugs to tackle the virus directly are only just heading into the last stage of trials, with Merck and Pfizer launching the studies...
...Another drug type — antiviral pills made by Pfizer and Merck of the US — is expected to work just as well against Omicron because, unlike the antibodies, these treatments disrupt enzymes that all coronaviruses...
...Good evening, New data today showed US companies added just 210,000 jobs in November, a sharp slowdown from the previous month and the lowest monthly total in nearly a year....
...Soren Christiansen, Merck’s former head of vaccine development, now chief executive of Sharps Technology, said that after early negative data, Merck probably concluded it had “missed the boat” and that mRNA...
...Treatments: The UK said it had secured deals with Merck and Pfizer for Covid-19 antiviral drugs for elderly and vulnerable groups to help ease pressure on the NHS over the winter....
...Founder Merck Mercuriadis told the Financial Times that Hipgnosis would continue to cherry-pick catalogues over the next two to three years as it doubles its base of songs and delivers on its promise to...
...Merck Sector: PHARMA / HQ: KENILWORTH, us Merck faces a growth challenge because of the loss of exclusivity on its multibillion-dollar cancer drug Keytruda towards the end of the decade....
International Edition